Company intelligence / Profile preview

K2 Bio Partners

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

K2 Bio Partners is the dedicated early-stage healthcare and life sciences investment arm of Xianfeng (K2 Venture Partners), a prominent venture capital firm headquartered in Beijing. Established in 2016, the firm operates as a venture studio and investment fund, focusing on identifying high-potential platform technologies and assisting scientists in establishing biotech startups from inception. K2 Bio Partners is recognized for its systematic research and deep involvement in translating innovative modalities—such as RNA interference (RNAi), circular RNA, and molecular glues—into transformative therapeutics. The firm has been instrumental in the launch and development of several leading biotechs, including SanegeneBio, Fortitude Biomedicines, and GluBio Pharmaceutical, with a therapeutic focus spanning oncology, immunology, and metabolic disorders.

Therapeutic areas: HematologyImmunologyEndocrinologyCardiovascularNeurologyOncology
Modalities: RNA interferenceCircular RNAMolecular glue therapyAntibody-drug conjugatemRNA-based drugsGene therapyCell therapySmall moleculeLipid nanoparticle delivery therapy
Industry: Investors

Partnerships

Shanghai Healthcare Angel CapitalElikon VentureBaylor College of Medicine

Beyond the preview

Go deeper on K2 Bio Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on K2 Bio Partners.

Explore the full profile